PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Zonghong Lu

Department of Thyroid and Breast Surgery, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

MAY 26, 2026 · JOURNAL ARTICLE

Suppression of LncRNA AC008406.3 sensitizes breast cancer cells to docetaxel via triggering cuproptosis.

Cancer Biology & Therapy

In vitro and database study identifying lncRNA AC008406.3 as a cuproptosis regulator affecting docetaxel sensitivity in breast cancer cells, lacking clinical validation or human efficacy data.

PreliminaryLin Zhang Xenograft Model Antitumor Assays Lncrna

Study details

DesignIntegrated TCGA database analysis with in v…

InterventionAC008406.3 knockdown and overexpression in…

ComparatorControl cells without AC008406.3 manipulati…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support